10-08-2026 16:08 via drugs.com

New Melanoma Drug, Tudriqev, Based On Herpes Virus Granted FDA Accelerated Approval

MONDAY, Aug. 10, 2026 — Federal regulators have granted accelerated approval to a novel therapy for advanced melanoma — giving doctors another weapon to fight this challenging skin cancer.
Tudriqev is an oncolytic viral therapy, which...
Read more »

Pharmaceutical news



Burnout Common Among Psychiatric Mental Health Registered Nurses
FDA Approves First Self-Balancing, Personal Exoskeleton
States Enact Emergency Orders On Kratom While Awaiting Federal Rules
Suboptimal Adherence to Brain Health Recommendations Common in Early Alzheimer Disease
Genomic Newborn Screening Could ID Cancer Predisposition Syndrome
Report Highlights Substance Use in Young Adults in U.S. in 2025
Imaging Turnaround Time Increased From 2023 to 2024
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy
Processed Foods Linked To Prostate Cancer Risk
Screen Time Is Not All Bad For Kids' Brains
Winter Is Coming: How Vaccines Help Protect Against Respiratory Illness
Sleep Disturbances Linked To Genetic Alzheimer's Risk
Pre-K Sets Kids Up For School Success, Study Says
Expect Other Seniors To Act Their Age? Then Expect Problems With Your Own Memory, Study Says
Desktop versie